Search by Drug Name or NDC
NDC 58468-0050-01 XENPOZYME 20 mg/5.1mL Details
XENPOZYME 20 mg/5.1mL
XENPOZYME is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Genzyme Corporation. The primary component is OLIPUDASE ALFA.
Product Information
| NDC | 58468-0050 |
|---|---|
| Product ID | 58468-0050_30470c72-f91b-4074-99d6-3d5e265b1542 |
| Associated GPIs | |
| GCN Sequence Number | 083789 |
| GCN Sequence Number Description | olipudase alfa-rpcp VIAL 20 MG INTRAVEN |
| HIC3 | Z14 |
| HIC3 Description | METABOLIC DISEASE ENZYME REPLACEMENT, ASMD |
| GCN | 52847 |
| HICL Sequence Number | 048267 |
| HICL Sequence Number Description | OLIPUDASE ALFA-RPCP |
| Brand/Generic | Brand |
| Proprietary Name | XENPOZYME |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | olipudase alfa-rpcp |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/5.1mL |
| Substance Name | OLIPUDASE ALFA |
| Labeler Name | Genzyme Corporation |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761261 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 58468-0050-01 (58468005001)
| NDC Package Code | 58468-0050-1 |
|---|---|
| Billing NDC | 58468005001 |
| Package | 1 VIAL in 1 CARTON (58468-0050-1) / 5.1 mL in 1 VIAL |
| Marketing Start Date | 2022-08-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |